[1]
I. A. Burney, A. K. Kakaria, and S. Al-Jahdhami, “Complete Response to Sorafenib in Locally Recurrent Unresectable Aggressive Fibromatosis”, Sultan Qaboos Univ Med J, vol. 21, no. 2, pp. e327–328, Jun. 2021.